Trials / Unknown
UnknownNCT04815200
Efficiency of Using Copper-Nickel-Titanium Versus Nickel-Titanium Arch Wires on Anterior Segment Crowding Alleviation in Group of Adults With Moderate Crowding
Efficiency of Using Copper-Nickel-Titanium Versus Nickel-Titanium Arch Wires on Anterior Segment Crowding Alleviation in Group of Adults With Moderate Crowding: A Randomized Controlled Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 33 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the efficiency of using copper nickel titanium (CuNiTi) arch wire on the initial stage of leveling and alignment regarding their rate of alignment in comparison to Conventional Nickel Titanium arch wire (NiTi) by Measuring the amount and rate of alignment achieved every 2 weeks for a period of 2 months. .
Detailed description
Leveling and alignment is the first stage in fixed orthodontic treatment, performed for every patient. Copper nickel titanium (CuNiTi) was modified from conventional nickel titanium (NiTi) to stabilize the super elasticity properties of the initial nickel titanium (NiTi) arch wire against cyclic deformation. The addition of copper to traditional nickel titanium enhances thermal reactive properties and consistency of forces.so the aim of the study is to Evaluate the efficiency of using copper nickel titanium (CuNiTi) arch wire on the initial stage of leveling and alignment regarding their rate of alignment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Copper Nickel titanium arch wire | Patient will receive 0.014 round Copper Nickel titanium CuNiTi archwire and will be ligated using a ligature wire. |
Timeline
- Start date
- 2021-03-18
- Primary completion
- 2022-03-18
- Completion
- 2022-04-18
- First posted
- 2021-03-24
- Last updated
- 2021-03-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04815200. Inclusion in this directory is not an endorsement.